Anupam Rasayan India Limited — Updates, 23-05-2026: Press Release
23-05-2026 · 09:10 pm
Anupam Rasayan will acquire 43.3-48.2% equity in Bliss GVS Pharma, plus an Open Offer. This strategic move, partly funded by a Rs 300 Cr term loan, aims to build an integrated global life sciences platform, strengthening its pharma value chain and global reach.
No comments yet. Be the first to comment!
